Blue-chip shares gained for a third straight day in London, sending the FTSE 100 index up 17.70 poin...
Blue-chip shares gained for a third straight day in London, sending the FTSE 100 index up 17.70 points to 3,771.10 by the close.
Canary Wharf managed to snap a losing streak, becoming the best performer with a 7.5p gain to 140p after reports that major investment bank Lehman Bros. is still set to go through with its move to new headquarters in the Docklands.
BSkyB jumped 19.5p to 663p after the European Union cleared owner Rupert Murdoch's purchase of Italian television station Telepiu, which fills a big hole in the company's European expansion plans.
ICI gained 2.75p to 99p after ICI Paints in the US saw a lawsuit alleging damages from lead-based paints thrown out of court.
Reckitt Benckiser dropped, however, after its biggest shareholder sold 5% of its shares – the stock lost 40p to £10.58.
AstraZenica shed 75p to £21.90 after analysts cut their recommendations on the stock to 'neutral' from 'buy'.
The FTSE 250 gained 16.4 points to 4,040.7.
Celltech was a winner as competition authorities said they would not investigate its bid for Oxford Glycosciences, and shares rose 19p to 295p.
Investec climbed 32.5p to 655p despite being told that a former employee had been given right to appeal for a fresh hearing into a sexual discrimination case, and after news that SCMB Securities was maintaining the stock as an 'underperform' recommendation.
Poor results from toilet cleaner PHS Group led its shares down 6.5p to 61.5p.
In New York, shares have been trading marginally down so far today.
The Dow Jones Industrial Average index is off by 20 points to 8,265, although the Nasdaq Composite is up by about 1 point to 1,397.
Joint life second death option added to relieve tax burden on couples gifting assets
Backed by Schroders, LGIM and the IA
New system for funds without without three-year track record
Clients to be compensated by end of 2018
Rolled out to 25 schemes next month